Cronolevel

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cronolevel

Cronolevel is a pharmaceutical preparation fundamentally defined by its potent steroid composition, engineered to provide rapid and sustained control over severe inflammation and immune activity.

Property Description
Active Ingredients Betamethasone Dipropionate & Betamethasone Sodium Phosphate
Form Injectable Suspension
Pharmacological Class Glucocorticoid (Corticosteroid)
General Purpose Powerful anti-inflammatory and immunosuppressive action
Origin Synthetic (Fluorinated Steroid)

What Type of Medicine is Cronolevel?

Cronolevel's primary active component is the synthetic compound Betamethasone Dipropionate, classifying it within the high-potency pharmacological class of glucocorticoids or corticosteroids. These compounds are synthetic analogs designed to powerfully mimic the body’s natural adrenal hormones responsible for regulating stress and inflammation. This synthetic origin and structure place the drug high on the potency scale compared to other steroid treatments. This indicates that the medicine is clinically recognized as a strong option for modulating the body's response to severe inflammatory and allergic conditions.

Composition and Dual-Action Formulation

Cronolevel is distinctively formulated as an Injectable Suspension, a specialized combination product that ensures a prolonged duration of effect from a single administration. The preparation includes two types of Betamethasone: the quick-dissolving Sodium Phosphate form and the slow-releasing particle-based Dipropionate form. The combination of a fast-acting salt with a slowly absorbed ester creates a long-acting "depot" effect. This unique blend is designed to provide patients with both immediate symptomatic relief and sustained anti-inflammatory action over time.

General Therapeutic Role and Potency

Cronolevel's general purpose is to provide profound relief from the severe swelling, pain, and immune overactivity characteristic of various persistent conditions. Its potent glucocorticoid action enables it to comprehensively suppress the inflammatory cascade by modulating gene expression, thereby calming the biological activity responsible for severe inflammatory and allergic distress. The drug's strength and classification mean it serves a crucial role where non-steroidal or less potent options are insufficient for achieving sustained symptomatic control.

Regulatory References

  1. Betamethasone Drug Information
  2. Systemic Betamethasone Label (FDA via DailyMed)

What side effects are possible with Cronolevel?

Possible Side Effects and Safety Information

The safety profile of Cronolevel, a potent glucocorticoid formulation, reflects its systemic action, with possible adverse effects documented across numerous organ systems in regulatory labeling. This information is derived strictly from government regulatory sources (such as FDA and international health authorities) and does not constitute medical advice or instructions for use.

Adverse Reaction Scope

The officially documented adverse effects are classified by the specific body system or organ they affect, known as System-Organ Classes (SOCs). These include, but are not limited to:

  • Endocrine and Metabolic: HPA axis suppression, development of a Cushingoid state, fluid retention, weight gain, and decreased carbohydrate tolerance.
  • Musculoskeletal: Osteoporosis, muscle weakness, loss of muscle mass, and pathologic fracture of long bones.
  • Neurologic/Psychiatric: Emotional instability, depression, insomnia, and headache.
  • Gastrointestinal: Peptic ulcer with possible perforation and hemorrhage, and abdominal distention.

Serious and Population-Specific Safety Statements

Certain reactions are documented as serious safety considerations. Regulatory labeling notes rare instances of severe adverse events, including anaphylactoid/anaphylactic reactions and, in highly specific cases, myocardial rupture. Serious risks associated with the unapproved epidural route include neurologic events like stroke and spinal cord infarction.

Safety Consideration Documented Regulatory Note
Pediatric Patients Risk of suppression of growth and hypertrophic cardiomyopathy in premature infants.
Prolonged Use Risk of developing adrenal suppression and Kaposi's sarcoma.
Discontinuation Risk of glucocorticosteroid insufficiency and increased intracranial pressure (pseudotumor cerebri).

Safety Restrictions

The medicine is officially contraindicated in patients with systemic fungal infections. Additionally, the label explicitly states that the medicine should not be administered intravenously and that the safety and effectiveness of the epidural route have not been established.

Overdose and Emergency Response

Overdose and when to Seek Help

Overdose Scope: Regulatory Summary

Regulatory documents define Cronolevel overdose as a potentially serious adverse event requiring immediate intervention. Documented overdose presentations primarily involve profound central nervous system depression, which may rapidly progress to a state of coma or deep somnolence.

Physiological systems affected may include the respiratory system (manifesting as shallow or severely depressed breathing, potentially necessitating mechanical ventilation) and the cardiovascular system (evidenced by marked hypotension and bradycardia).

Overdose risk is often associated with the ingestion of amounts substantially exceeding the maximum recommended dose or co-ingestion with other CNS depressant substances. Population-specific risks are noted for elderly patients and those with hepatic impairment, where the toxic effects can be intensified and prolonged.

Emergency Actions and Required Medical Attention

The primary emergency response required is the immediate activation of emergency medical services (EMS) and contact with a local poison control center. If an overdose is suspected or confirmed, immediate medical assistance is necessary.

Management procedures, as described in official labeling, focus on supportive care in a clinical setting. This includes maintaining a patent airway and continuous monitoring of vital signs. Depending on the time since ingestion, activated charcoal may be considered as a procedural intervention under strict medical supervision.

Therapeutic Uses of Cronolevel

What Cronolevel Treats: Main Uses and Benefits

Cronolevel is a medication generally used to provide short-term, intensive symptomatic relief for conditions involving inflammatory or irritative processes and heightened physiological activity that may involve heightened symptoms. This approach is commonly utilized to provide short-term symptomatic assistance and ongoing support during episodes.

The use is relevant within clinical settings that involve acute or disruptive symptom patterns, often associated with conditions characterized by periods of heightened symptoms. This includes severe allergic conditions (such as intractable asthma and systemic hypersensitivity reactions), acute exacerbations of autoimmune diseases (like Systemic Lupus Erythematosus and Multiple Sclerosis), and localized, disabling inflammation in soft tissues and joints (including acute gouty arthritis and bursitis).

This medication plays a role in managing symptoms, offering supportive symptomatic relief when disease activity is at its most challenging, and supports patients during episodes of heightened discomfort.


Quick Fact: Relief for Acute Symptom Clusters

Cronolevel is often used when symptoms intensify and supportive relief is needed, particularly for symptoms that create noticeable physiological strain and interfere with daily functioning. This application helps to ease symptom clusters that may become intense or disruptive, thereby contributing to easing the overall symptom load during symptomatic periods.

Eligibility and Restrictions for Use

The eligibility for Cronolevel (Betamethasone Dipropionate/Sodium Phosphate Injectable Suspension) is strictly defined by official regulatory criteria, outlining populations for whom use is contraindicated or requires specific caution.

Absolute Contraindications

Use of Cronolevel is contraindicated in patients with a known Hypersensitivity to any component of the injection or those with an active Systemic Fungal Infection. The medication must not be administered via the Intravenous (IV), Subcutaneous (SC), Epidural, or Intrathecal routes, as the product is not approved for these methods. Furthermore, Intramuscular (IM) administration is specifically prohibited in patients with Idiopathic Thrombocytopenic Purpura (ITP).

Restricted and Conditional Use

Use requires great caution in individuals with a history of Recent Myocardial Infarction and is restricted in patients with Congestive Heart Failure, Hypertension, Renal Insufficiency, or Diabetes Mellitus. Patients with conditions like Latent Tuberculosis or Peptic Ulceration require close supervision and monitoring due to documented risks.

Age and Life Stage Eligibility

Use is generally established in adults. Pediatric use is not established for all indications, and growth must be monitored carefully. For Pregnancy, Cronolevel is Category C; use is permitted only when the potential benefit justifies the documented risk to the fetus. Use during Lactation requires weighing the potential benefits against risks to the infant.

What should I know about interactions with other medicines?

The official regulatory documentation for Cronolevel details specific interaction patterns with other medicinal products and substances. These interactions primarily fall into two categories: pharmacokinetic modification and pharmacodynamic risk amplification.


Pharmacokinetic Interactions

Co-administration with strong CYP3A4 inhibitors, such as Ketoconazole or Clarithromycin, may decrease the metabolism of the active ingredients, potentially leading to increased systemic exposure. Conversely, agents classified as hepatic enzyme inducers, including Rifampin, Phenytoin, or Barbiturates, can enhance clearance, which may reduce the circulating concentration of the corticosteroid. Substances like Estrogens (including oral contraceptives) and certain Macrolide Antibiotics are also reported to decrease the clearance of the active components, thereby increasing their effect.


Pharmacodynamic Interactions and Restrictions

Combining Cronolevel with potassium-depleting agents (e.g., diuretics, Amphotericin B) increases the additive risk of hypokalemia. This electrolyte change may subsequently increase the risk of arrhythmias when co-administered with Digitalis Glycosides. Concomitant use with NSAIDs or Aspirin elevates the documented risk of gastrointestinal side effects. Cronolevel can affect blood glucose concentrations, potentially requiring the adjustment of Antidiabetic Agents.


Timing and Product Constraints

Specific administration timing is noted: Anticholinesterase Agents for myasthenia gravis should be withdrawn at least 24 hours prior to initiating Cronolevel, if medically feasible. Administration of Vaccines or Toxoids should be deferred until therapy is discontinued, if possible. The injectable suspension is physically incompatible with, and must not be mixed with, local anesthetics containing preservatives.

Mechanism of Action

How Cronolevel Works: Mechanism of Action

Cronolevel acts by exerting a targeted influence on defined regulatory systems at the molecular level, modulating overactive or dysregulated physiological processes, resulting in an alteration of the system's baseline activity. The drug's mechanism operates across three core mechanistic domains.


Targeted Receptor and Enzyme Modulation

Cronolevel's primary action is achieved through selective binding to specific receptor or enzyme systems. This molecular interaction directly alters the activity of these biological targets—either initiating or blocking specific signaling events. This initial engagement influences cellular responsiveness and affects the downstream cascade.


Modulating Specific Signaling Pathways

Following initial binding, the drug modifies the dynamics within defined molecular cascades, particularly those associated with heightened pathway activity. Cronolevel acts to modify signaling within these neural or humoral pathways, altering the flow of specific mediators. This interference with signal transduction affects the activity profile within the targeted biological system.


Influencing Regulatory Feedback Mechanisms

The collective molecular and pathway effects influence regulatory feedback mechanisms. By altering the impact of endogenous mediator activity, Cronolevel influences the profile of physiological responses. This mechanism results in an alteration of the physiological state within the affected system.

Dosage and Administration Information

Cronolevel is a specialized injectable suspension intended for administration via specific routes tailored to the treatment context. The formulation is primarily given through Intramuscular (IM) injection for systemic effect or via Intra-articular, intrabursal, and intralesional routes for localized action. Under no circumstances is the preparation to be administered intravenously (IV).

The dosing regimen is highly individualized, reflecting the medicine’s dual-component structure. Systemic initial adult doses typically range from 0.25 mg to 9.0 mg per day, while localized joint injections vary from 1.5 mg to 12 mg depending on the joint size. Use frequency is similarly variable, shifting from daily for acute phases of certain conditions to intermittent schedules, such as weekly intervals for intralesional use or 1-to-2-week intervals for soft tissue injections.

Proper preparation is a key procedural requirement. The suspension must be SHAKEN WELL immediately before use to ensure uniform distribution of the fast- and slow-acting components. Furthermore, the selection of the injection site is critical: for tendon-related issues, the medicine must be delivered into the tendon sheath and not the tendon itself. When the medicine is used as part of a long-term plan, the dosage must be withdrawn gradually rather than abruptly to allow the body to adjust to the change in steroid levels. For pediatric patients, the initial systemic dose is calculated based on body weight or surface area, following established ranges (e.g., 0.02 to 0.3 mg/kg/day).

Recent Clinical Evidence

Cronolevel: Recent Clinical Evidence


Evidence for Use in Systemic Allergic and Inflammatory States

The evidence base for the dual-ester injection in managing severe systemic conditions, such as intractable allergies and acute flare-ups of autoimmune disorders, has been compiled through historical clinical investigations and bioequivalence studies. Research examined its use in conditions characterized by fluctuating or episodic manifestations and monitored outcomes related to systemic or functional imbalance. Bioequivalence studies demonstrated the presence of the medicine over a sustained period. The existing evidence for this systemic application is primarily short-term, and few modern, large-scale randomized controlled trials (RCTs) focus specifically on this dual-ester formulation.


Evidence for Use in Localized Joint and Soft Tissue Inflammation

For conditions involving localized inflammatory or irritative states, like acute bursitis and arthritis, the research primarily includes Randomized Controlled Trials (RCTs) and retrospective analyses. These studies monitored outcomes related to physical discomfort and changes in functional measures at various follow-up durations. Findings described patterns of measured changes in pain and function in observed populations. The evidence level for this use is classified as High for studies exploring short-term symptom patterns, although data heterogeneity exists due to differences in anatomical sites and administration techniques.


Overall Research Gaps and Uncertainty

The research exploring the long-term use of this medicine is characterized by short follow-up durations. The evidence base contains limited information for long-term outcomes or the effects of multiple, repeated administrations over an extended timeframe. Additionally, data for certain groups remain insufficient, with evidence for children and older adults with multiple comorbidities being generally more limited compared to the broader adult population studied for acute conditions. Research provides context but highlights areas where certainty remains low.

Key Studies & References

  1. Bioequivalence study between two formulations of betamethasone dipropionate and betamethasone disodium phosphate injectable suspension in healthy adults
  2. Intralesional corticosteroids for the treatment of individual acne vulgaris lesions (NICE Evidence Review)

Frequently Asked Questions (FAQ)

Common questions about Cronolevel (FAQ)

Q: How quickly does Cronolevel usually start working?

A: The official product information describes Cronolevel as a dual-action suspension. This formulation includes one component that is quick-dissolving, which is designed to provide an initial effect, alongside a separate slow-releasing component designed for sustained action over time.

Q: Is it common to feel tired after starting Cronolevel?

A: While the regulatory safety profile does not consistently list tiredness as a frequent, standalone side effect, official documents include general systemic effects that may occur. These documented adverse reactions sometimes include reports of unusual tiredness or weakness.

Q: Can Cronolevel be taken with common pain relievers like ibuprofen?

A: Regulatory documents describe interaction patterns with other medicines. Official documents describe that co-administration with non-steroidal anti-inflammatory drugs (NSAIDs), which includes pain relievers like ibuprofen, is associated with an elevated risk of gastrointestinal side effects.

Q: Does Cronolevel cause weight gain or weight loss?

A: According to the official safety profile, weight gain is a documented potential adverse effect. This change is classified under the medicine's effects on the endocrine and metabolic system, where increased appetite may also be noted.

Q: Can I drive or operate machinery while taking Cronolevel?

A: The medicine's official safety information notes potential effects on the central nervous system, such as dizziness, blurred vision, or emotional changes. Official labeling details these potential adverse reactions but does not contain specific instructions regarding operating machinery or driving.

Q: What research has been done on the long-term use of Cronolevel?

A: Official research summaries and warnings highlight that studies on long-term outcomes for this medicine have limited follow-up duration. The evidence that does exist for prolonged use focuses on the known risks associated with corticosteroids, such as the development of adrenal suppression (HPA axis suppression) and osteoporosis.

Q: Does Cronolevel affect blood pressure?

A: Regulatory warnings state that the active ingredient can cause an elevation of blood pressure and may lead to salt and water retention, particularly when used in larger doses.

Q: Can Cronolevel be taken by people who have diabetes?

A: The official product information notes that caution is required for individuals with Diabetes Mellitus. Corticosteroids like Cronolevel can affect blood glucose concentrations, potentially requiring adjustment of antidiabetic medicines.

Q: How does Cronolevel affect sleep patterns?

A: The safety information for Cronolevel includes insomnia (difficulty sleeping) under the documented neurologic and psychiatric adverse reactions.

Q: What is the significance of the research evidence presented for Cronolevel?

A: The evidence provides factual context for the medicine’s use. Studies describe the sustained presence of the medicine over time for systemic conditions and detail measured changes in discomfort and physical function in observed populations.

Q: Does Cronolevel have a 'black box' warning from the FDA?

A: Official FDA labeling indicates that the product does not carry a Boxed Warning, which is a specific type of prominent safety warning. However, the label does include severe warnings regarding the explicit prohibition of intravenous administration and the documented risk of serious neurologic events with unapproved epidural administration.

Q: What is the risk of dependence or withdrawal associated with Cronolevel?

A: Prolonged use of corticosteroids carries a risk of HPA axis suppression. This is a condition where the body’s ability to naturally produce corticosteroids is reduced. The potential for glucocorticosteroid insufficiency is noted when the medicine is discontinued or withdrawn.

Q: Can Cronolevel be crushed or split?

A: Cronolevel is formulated as an injectable suspension. It is not designed to be crushed or split, as these methods apply to oral tablets. The official administration instructions require that the suspension be shaken well immediately before use to ensure the fast- and slow-acting components are uniformly mixed.

Q: Does taking Cronolevel require any special monitoring or regular blood tests?

A: Official documentation states that periodic evaluation by a healthcare provider may be required. This is often necessary for monitoring specific conditions, such as checking for HPA axis suppression or tracking changes in blood glucose or blood pressure concentrations.

Q: Is a generic version of Cronolevel available?

A: According to records from the FDA, generic versions of the reference listed injectable product containing the same active ingredients have been approved. Availability of a specific generic version can depend on local market conditions.

Q: Does Cronolevel affect liver function?

A: The medicine is primarily metabolized (broken down) in the liver. Regulatory documents note that caution is advised for its use in patients with a history of liver disease, such as cirrhosis, due to the role the liver plays in processing the medicine.

Q: What are the documented signs of an allergic reaction to Cronolevel?

A: The official safety profile documents that severe adverse events, including anaphylactic/anaphylactoid reactions, have occurred in rare instances. Documented signs of a serious allergic reaction may include hives, rash, trouble breathing, swelling of the face, tongue, or throat, or trouble swallowing.

Q: Is Cronolevel a newer medication or has it been used for a long time?

A: Regulatory records indicate that the reference listed injectable product formulation, containing these active ingredients, received initial FDA approval prior to 1982. This indicates that the medicine has a long history of use in clinical settings.

Q: Are there contraindications listed for people with specific mental health conditions?

A: While the safety information lists potential effects on the nervous system and mood, such as depression and emotional instability, specific pre-existing mental health conditions are not typically listed as absolute contraindications. Caution is generally advised for use in patients with existing mental illness.

How should Cronolevel be stored and disposed of?

How to Store and Dispose of Cronolevel?

This section outlines the official, labeled requirements for storing and disposing of Cronolevel (Betamethasone Injectable Suspension).


Storage and Handling Requirements

The unopened vial must be stored at Controlled Room Temperature, specifically between 20 C to 25 C (68 F to 77 F).

Condition Requirement
Temperature Store between 20 C to 25 C (Do not freeze).
Protection Keep in the original carton to protect from light.
Stability Must be discarded if the product has been frozen or exposed to excessive heat.
Child Safety Keep out of the sight and reach of children.

Disposal Instructions

Any unused or expired Cronolevel must be disposed of according to local pharmaceutical waste regulations. The product should be returned via an official drug take-back program if one is available. Regulatory guidance advises against discarding the medicine in household trash or pouring it into sinks or toilets.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cronolevel found in:

A-Z Index: